Direxion Daily CSI China Internet Bull 2X Shares vs Hims and Hers Health Inc — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.25 (market cap $176.60M), while Hims and Hers Health Inc trades at $28.41 (market cap $6.89B). The key difference: Hims and Hers Health Inc is far larger — about 39× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Direxion Daily CSI China Internet Bull 2X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and Hims and Hers Health Inc for 21 Days on average.
| CWEB | HIMS | |
|---|---|---|
Market Cap | $176.60M | $6.89B |
Volume | 440,349 | 5,446,628 |
Sector | Leveraged / Inverse | Health |
52-Week High | $55.62 | $62.76 |
52-Week Low | $17.39 | $14.52 |
Typical Hold Time | 24 Days | 21 Days |
Enterprise Value | — | $7.60B |
Signals from Pluang's Aura AI — not financial advice
CWEB trades at $18.02, down 1.85% today amid bearish technical signals. The stock shows weak momentum with all 13 moving averages signaling sell, though oscillators are neutral. Recent news highlights China's AI ambitions and potential for China growth stocks to surge, providing thematic catalysts. Financial ratios remain undisclosed in current data.
Outlook hinges on China's tech sector recovery and AI growth narrative. Risks include geopolitical tensions and market volatility. The upcoming dividend of $0.07 in September 2026 offers income potential, but investors need clarity on fundamentals for sustained upside.
Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.
The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →